Adjuvant Pembrolizumab After Nephrectomy in Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Adjuvant Pembrolizumab After Nephrectomy in Renal-Cell Carcinoma
N. Engl. J. Med 2021 Aug 19;385(8)683-694, TK Choueiri, P Tomczak, SH Park, B Venugopal, T Ferguson, YH Chang, J Hajek, SN Symeonides, JL Lee, N Sarwar, A Thiery-Vuillemin, M Gross-Goupil, M Mahave, NB Haas, P Sawrycki, H Gurney, C Chevreau, B Melichar, E Kopyltsov, A Alva, JM Burke, G Doshi, D Topart, S Oudard, H Hammers, H Kitamura, J Bedke, RF Perini, P Zhang, K Imai, J Willemann-Rogerio, DI Quinn, T PowlesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.